Intraocular inflammation secondary to intravitreal brolucizumab treated successfully with Sub-Tenon triamcinolone: A case report

PURPOSE: To report on a case of successful treatment of intraocular inflammation (IOI) secondary to brolucizumab intravitreal injection that responded to a single sub-Tenon injection of triamcinolone. OBSERVATIONS: An 81-year-old female with a longstanding history of exudative age-related macular de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurup, Shree K., Tabbaa, Tarek, Echegaray, Jose J., Oliver, Armando L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802001/
https://www.ncbi.nlm.nih.gov/pubmed/35146186
http://dx.doi.org/10.1016/j.ajoc.2022.101289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802001/
https://www.ncbi.nlm.nih.gov/pubmed/35146186
http://dx.doi.org/10.1016/j.ajoc.2022.101289

Ejemplares similares